Loratadine versus levocetirizine in chronic idiopathic urticaria: A comparative study of efficacy and safety

Indian Journal of Pharmacology

Volumn 42, Issue 1, 2010, Pages 12-16

  Anuradha, P ^a   Maiti, Rituparna ^a   Jyothirmai, J ^a   Mujeebuddin, Omer ^a   Anuradha, M ^a  

^a Prathima Institute of Medical Sciences   (India)

Author keywords

Absolute eosinophil count; Chronic idiopathic urticaria; Levocetirizine; Loratadine; Total symptom score

Indexed keywords

LEVOCETIRIZINE; LORATADINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC URTICARIA; CLINICAL ASSESSMENT; CLINICAL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; HEADACHE; HUMAN; IDIOPATHIC DISEASE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; OPEN STUDY; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STOMACH IRRITATION; TREATMENT DURATION; XEROSTOMIA;

EID: 77951693842     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.62399     Document Type: Article

References (17)

1. Grattan C, Powell S, Humphreys F. Management and diagnostic guidelines for urticaria and angio-oedema. Br J Dermatol 2001;144:708-14.
2. Kapp A, Pichler WJ. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: A randomized, double-blind, placebo-controlled, parallel, multicenter study. Int J Dermatol 2006;45:469-74.
3. Nettis E, Colanardi MC, Barra L, Ferrannini A, Vacca A, Tursi A. Levocetirizine in the treatment of chronic idiopathic urticaria: A randomized, double-blind, placebo-controlled study. Br J Dermatol 2006;154:533-8.
4. Zuberbier T, Maurer M. Urticaria: Current opinions about etiology, diagnosis and therapy. Acta Derm Venereol 2007;87:196-205.
5. th World Congress of Dermatology 1987 West Berlin.
6. Haria M, Filton A, Peters DH. Loratadine: A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs 1994;48:617-37
7. Thomas J, Pandhi RK, Oberoi C, Bandopad. A multicentric trial of Loratadine and cetirizine chronic urticaria. Indian J Dermatol Venerol Leprol 1998;64:12-5
8. Garg G, Thami GP. Comparative effcacy of cetirizine and levocetirizine in chronic idiopathic urticaria. J Dermatolog Treat 2007;18:23-24
9. Caproni M, Volpi W, Giomi B, Torchia D, Del Bianco E, Fabbri P. Cellular adhesion molecules in chronic urticaria: Modulation of serum levels occurs during Levocetirizine treatment. Br J Dermatol 2006;155:1270-4.
10. Walsh GM. Levocetirizine: An update. Curr Med Chem 2006;13:2711-5
11. Pfaar O, Wrede H, Barth C, Hansen I, Klimek L. Levocetirizine in patients with chronic idiopathic urticaria: Results of a multicenter clinical practice study. Int J Clin Pharmacol Ther 2006;44:191-2
12. Wu P, Mitchell S, Walsh GM. A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions. Clin Exp Allergy 2005;35:1073-9
13. Molimard M, Diquet B, Benedetti MS. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fundam Clin Pharmacol 2004;18:399-411
14. Clough GF, Boutsiouki P, Church MK. Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin. Allergy 2001;56:985-8
15. Hair PI, Scott LJ. Levocetirizine: A review of its use in the management of allergic rhinitis and skin allergies. Drugs 2006;66:973-96.
16. Popov TA, Dumitrascu D, Bachvarova A, Bocsan C, Dimitrov V, Church MK. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo. Infamm Res 2006;55:241-4
17. Layton D, Wilton L, Boshier A, Cornelius V, Harris S, Shakir SA. Comparison of the risk of drowsiness and sedation between Levocetirizine and desloratadine: A prescription-event monitoring study in England. Drug Saf 2006;29:897-909